Animal Primary Cells Market By Donor ( Mouse, Rat, Bovine, Porcine ), By Cell Type ( Endothelial cells, Epithelial cells, Muscle cells, Keratinocytes, Fibroblasts ), By Application ( Medical research, Clinical research ), Industry Trends, Estimation & Forecast, 2017 - 2025

Check Today's Best Price

$3500 Buy Now
Animal Primary Cells Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.
  • Market Overview:

    The cells isolated from animal tissue by an enzymatic or mechanical method are known as animal primary cells. Primary cells derived directly from the animal tissue contain heterogeneous cells that have the ability to divide for a limited duration of time. Animal primary cells are a crucial component of medical and clinical research as they form the research models used for vaccine development, cancer research, gene therapy, immunological studies and many more allied applications. The continuous advancements in technology and entrance of new players in the market are fuelling the growth of global animal primary cells market. The presence of numerous market players across the globe has led to the diversification of their product portfolio, enabling customers to select from a varied options.

    The characteristic of primary cells to replicate their original function in an in-vitro environment renders them fit for conducting several medical research studies. According to a research study, a major portion of the animal primary cells used for academic purposes are isolated and cultured within the lab, whereas, only a small portion of the primary cells are bought from a commercial source. Such a trend in the global market is expected to create hurdles during the growth of the animal primary cells market. In order to gain a competitive edge over their competitors, animal cell providers are offering extra services to their clients, along with an advanced product portfolio.

    The report provides detailed qualitative and quantitative analysis of the animal primary cells market. Market size and forecast in terms of value and volume has been provided for the period – (2017 – 2025), for the segments namely donor, cell type, and application in each of the major regions.

    Animal Primary Cells Market Segmentation

    By Donor
    • Mouse
    • Rat
    • Bovine
    • Porcine
    • Others (rabbit, canine, chicken, feline)

    By Cell Type
    • Endothelial cells
    • Epithelial cells
    • Muscle cells
    • Keratinocytes
    • Fibroblasts
    • Adipose cells
    • Astrocytes
    • Hematopoietic cells
    • Hepatocytes
    • Others

    By Application
    • Medical research
    • Clinical research

    By Geography
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources

    CHAPTER 2. ANIMAL PRIMARY CELLS MARKET OVERVIEW
    2.1. PRODUCT OVERVIEW AND SCOPE OF ANIMAL PRIMARY CELLS
    2.2. ANIMAL PRIMARY CELLS SEGMENT BY CELL TYPE (PRODUCT CATEGORY)
    2.2.1. Global Animal Primary Cells Production and CAGR (%) Comparison by Cell type (Product Category)(2012-2022)
    2.2.2. Global Animal Primary Cells Production Market Share by Cell type (Product Category) in 2016
    2.2.3. Endothelial cells
    2.2.4. Epithelial cells
    2.2.5. Adipose cells
    2.2.6. Keratinocytes
    2.2.7. Fibroblasts
    2.2.8. Adipose cells
    2.2.9. Astrocytes
    2.2.10. Hematopoietic cells
    2.2.11. Hepatocytes
    2.2.12. Others
    2.3. GLOBAL ANIMAL PRIMARY CELLS SEGMENT BY APPLICATION
    2.3.1. Animal Primary Cells Consumption (Sales) Comparison by Application (2012-2022)
    2.3.2. Medical Research
    2.3.3. Clinical Research
    2.4. GLOBAL ANIMAL PRIMARY CELLS SEGMENT BY DONOR
    2.4.1. Animal Primary Cells Consumption (Sales) Comparison by Donor (2012-2022)
    2.4.2. Mouse
    2.4.3. Rat
    2.4.4. Bovine
    2.4.5. Porcine
    2.4.6. Others (rabbit, canine, chicken, feline)
    2.5. GLOBAL ANIMAL PRIMARY CELLS MARKET BY REGION (2012-2022)
    2.5.1. Global Animal Primary Cells Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
    2.5.2. North America Status and Prospect (2012-2022)
    2.5.3. Europe Status and Prospect (2012-2022)
    2.5.4. China Status and Prospect (2012-2022)
    2.5.5. Japan Status and Prospect (2012-2022)
    2.5.6. Southeast Asia Status and Prospect (2012-2022)
    2.5.7. India Status and Prospect (2012-2022)
    2.6. GLOBAL MARKET SIZE (VALUE) OF ANIMAL PRIMARY CELLS (2012-2022)
    2.6.1. Global Animal Primary Cells Revenue Status and Outlook (2012-2022)
    2.6.2. Global Animal Primary Cells Capacity, Production Status and Outlook (2012-2022)

    CHAPTER 3. GLOBAL ANIMAL PRIMARY CELLS MARKET COMPETITION BY MANUFACTURERS
    3.1. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION AND SHARE BY MANUFACTURERS (2012-2017)
    3.1.1. Global Animal Primary Cells Production and Share by Manufacturers (2012-2017)
    3.2. GLOBAL ANIMAL PRIMARY CELLS AVERAGE PRICE BY MANUFACTURERS (2012-2017)
    3.3. MANUFACTURERS ANIMAL PRIMARY CELLS MANUFACTURING BASE, AND SALES AREA
    3.3.1. Animal Primary Cells Market Share of Top 3 and Top 5 Manufacturers
    3.3.2. Mergers & Acquisitions, Expansion

    CHAPTER 4. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)
    4.1. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION AND MARKET SHARE BY REGION (2012-2017)
    4.2. GLOBAL ANIMAL PRIMARY CELLS REVENUE (VALUE) AND MARKET SHARE BY REGION (2012-2017)
    4.3. GLOBAL ANIMAL PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2012-2017)
    4.4. NORTH AMERICA ANIMAL PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2012-2017)
    4.5. EUROPE ANIMAL PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2012-2017)
    4.6. CHINA ANIMAL PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2012-2017)
    4.7. JAPAN ANIMAL PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2012-2017)
    4.8. SOUTHEAST ASIA ANIMAL PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2012-2017)
    4.9. INDIA ANIMAL PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2012-2017)

    CHAPTER 5. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION BY REGION (2012-2017)
    5.1. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION BY REGION (2012-2017)
    5.2. NORTH AMERICA ANIMAL PRIMARY CELLS PRODUCTION (2012-2017)
    5.3. EUROPE ANIMAL PRIMARY CELLS PRODUCTION (2012-2017)
    5.4. CHINA ANIMAL PRIMARY CELLS PRODUCTION (2012-2017)
    5.5. JAPAN ANIMAL PRIMARY CELLS PRODUCTION (2012-2017)
    5.6. SOUTHEAST ASIA ANIMAL PRIMARY CELLS PRODUCTION (2012-2017)
    5.7. INDIA ANIMAL PRIMARY CELLS PRODUCTION (2012-2017)

    CHAPTER 6. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION, REVENUE (VALUE) BY CELL TYPE
    6.1. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION AND MARKET SHARE BY CELL TYPE (2012-2017)
    6.2. GLOBAL ANIMAL PRIMARY CELLS REVENUE AND MARKET SHARE BY CELL TYPE (2012-2017)
    6.3. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION GROWTH BY CELL TYPE (2012-2017)

    CHAPTER 7. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION, REVENUE (VALUE) BY DONOR
    7.1. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION AND MARKET SHARE BY DONOR (2012-2017)
    7.2. GLOBAL ANIMAL PRIMARY CELLS REVENUE AND MARKET SHARE BY DONOR (2012-2017)
    7.3. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION GROWTH BY DONOR (2012-2017)

    CHAPTER 8. GLOBAL ANIMAL PRIMARY CELLS MARKET ANALYSIS BY APPLICATION
    8.1. GLOBAL ANIMAL PRIMARY CELLS CONSUMPTION AND MARKET SHARE BY APPLICATION (2012-2017)
    8.2. GLOBAL ANIMAL PRIMARY CELLS CONSUMPTION GROWTH RATE BY APPLICATION (2012-2017)
    8.3. MARKET DRIVERS
    8.3.1. Potential Applications

    CHAPTER 9. GLOBAL ANIMAL PRIMARY CELLS MANUFACTURERS PROFILES/ANALYSIS
    9.1. LONZA
    9.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    9.1.2. Animal Primary Cells Product Category, Application and Specification
    9.1.2.1. Product A
    9.1.2.2. Product B
    9.1.3. Lonza Animal Primary Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    9.1.4. Main Business/Business OverviewCompany Profile
    9.2. THERMO FISHER SCIENTIFIC
    9.2.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    9.2.2. Animal Primary Cells Product Category, Application and Specification
    9.2.2.1. Product A
    9.2.2.2. Product B
    9.2.3. Thermo Fisher Scientific Animal Primary Cells Production, Revenue, Price and Gross Margin (2012-2017)
    9.2.4. Main Business/Business Overview
    9.3. SIGMA-ALDRICH
    9.3.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    9.3.2. Animal Primary Cells Product Category, Application and Specification
    9.3.2.1. Product A
    9.3.2.2. Product B
    9.3.3. Sigma-Aldrich Animal Primary Cells Production, Revenue, Price and Gross Margin (2012-2017)
    9.3.4. Main Business/Business Overview
    9.4. CURELINE
    9.4.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    9.4.2. Animal Primary Cells Product Category, Application and Specification
    9.4.2.1. Product A
    9.4.2.2. Product B
    9.4.3. Cureline Animal Primary Cells Production, Revenue, Price and Gross Margin (2012-2017)
    9.4.4. Main Business/Business Overview
    9.5. STEMCELL TECHNOLOGIES
    9.5.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    9.5.2. Animal Primary Cells Product Category, Application and Specification
    9.5.2.1. Product A
    9.5.2.2. Product B
    9.5.3. STEMCELL Technologies Animal Primary Cells Production, Revenue, Price and Gross Margin (2012-2017)
    9.5.4. Main Business/Business Overview
    9.6. CREATIVE BIOARRAY
    9.6.1. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
    9.6.2. ANIMAL PRIMARY CELLS PRODUCT CATEGORY, APPLICATION AND SPECIFICATION
    9.6.2.1. Product A
    9.6.2.2. Product B
    9.6.3. CREATIVE BIOARRAY ANIMAL PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2012-2017)
    9.6.4. Business Overview
    9.7. CHARLES RIVER LABORATORIES
    9.7.1. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
    9.7.2. ANIMAL PRIMARY CELLS PRODUCT CATEGORY, APPLICATION AND SPECIFICATION
    9.7.2.1. Product A
    9.7.2.2. Product B
    9.7.3. Charles River Laboratories ANIMAL PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2012-2017)
    9.7.4. Business Overview
    9.8. IXCELLS BIOTECHNOLOGIES USA, INC.
    9.8.1. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
    9.8.2. ANIMAL PRIMARY CELLS PRODUCT CATEGORY, APPLICATION AND SPECIFICATION
    9.8.2.1. Product A
    9.8.2.2. Product B
    9.8.3. iXCells Biotechnologies USA, Inc. ANIMAL PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2012-2017)
    9.8.4. Business Overview

    CHAPTER 10. ANIMAL PRIMARY CELLS MANUFACTURING COST ANALYSIS
    10.1. ANIMAL PRIMARY CELLS KEY RAW MATERIALS ANALYSIS
    10.1.1. Key Raw Materials
    10.1.2. Key Suppliers of Raw Materials
    10.2. PROPORTION OF MANUFACTURING COST STRUCTURE
    10.2.1. Raw Materials
    10.2.2. Labor Cost
    10.2.3. Other expenses
    10.3. MANUFACTURING PROCESS ANALYSIS OF ANIMAL PRIMARY CELLS

    CHAPTER 11. INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
    11.1. ANIMAL PRIMARY CELLS INDUSTRIAL CHAIN ANALYSIS
    11.2. UPSTREAM RAW MATERIALS SOURCING 108
    11.3. ANIMAL PRIMARY CELLS MAJOR MANUFACTURERS IN 2016
    11.4. DOWNSTREAM BUYERS

    CHAPTER 12. MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
    12.1. MARKETING CHANNEL
    12.2. MARKETING CHANNEL DEVELOPMENT TREND
    12.3. MARKET POSITIONING
    12.3.1. Pricing Strategy
    12.3.2. Brand Strategy
    12.4. DISTRIBUTORS/TRADERS LIST

    CHAPTER 13. MARKET EFFECT FACTORS ANALYSIS
    13.1. TECHNOLOGY PROGRESS
    13.2. CONSUMER NEEDS/CUSTOMER PREFERENCE CHANGE
    13.3. ECONOMIC/POLITICAL ENVIRONMENTAL CHANGE

    CHAPTER 14. GLOBAL ANIMAL PRIMARY CELLS MARKET FORECAST (2017-2022)
    14.1. GLOBAL ANIMAL PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE FORECAST (2017-2022)
    14.1.1. Global Animal Primary Cells Capacity, Production and Growth Rate Forecast (2017-2022)
    14.1.2. Global Animal Primary Cells Revenue and Growth Rate Forecast (2017-2022)
    14.1.3. Global Animal Primary Cells Price and Trend Forecast (2017-2022)
    14.2. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION FORECAST BY REGION (2017-2022)
    14.2.1. North America Animal Primary Cells Production, Revenue Forecast (2017-2022)
    14.2.2. Europe Animal Primary Cells Production, Revenue Forecast (2017-2022)
    14.2.3. China Animal Primary Cells Production, Revenue Forecast (2017-2022)
    14.2.4. Japan Animal Primary Cells Production, Revenue Forecast (2017-2022)
    14.2.5. Southeast Asia Animal Primary Cells Production, Revenue Forecast (2017-2022)
    14.2.6. India Animal Primary Cells Production, Revenue, Consumption Forecast (2017-2022)
    14.3. GLOBAL ANIMAL PRIMARY CELLS PRODUCTION, REVENUE AND PRICE FORECAST BY CELL TYPE (2017-2022)
    14.4. GLOBAL ANIMAL PRIMARY CELLS CONSUMPTION FORECAST BY APPLICATION (2017-2022)

    keyboard_arrow_up
  • • Thermo Fisher Scientific
    • Lonza
    • Sigma-Aldrich
    • STEMCELL Technologies
    • Creative Bioarray
    • Charles River Laboratories
    • Cureline
    • iXCells Biotechnologies USA, Inc.

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Animal Primary Cells Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Animal Primary Cells Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS